Developing a genetic toolkit for manipulating intestinal microbes

The ability to genetically manipulate these microbes could lead to a better understanding of the role they play in human physiology and diseases.

Research Matters returns, following ideas from the lab to real life 

The second season of Research Matters, a Cornell video podcast, drops today, with a way-too-relevant episode on why we don't always do the things we know we should.

Researchers find new clue to prostate cancer’s hormone therapy resistance

Prostate tumors can rewire amino acid metabolism to override the normal brakes on cholesterol production, a process that may fuel hormone therapy resistance, according to Weill Cornell Medicine researchers.

‘Wall-to-wall’ map of NYC trees could help cool cities worldwide

Researchers used satellite images to identify 1.8 million trees in New York City, a new approach that could be broadly implemented to increase cooling and improve air quality in cities.

Aspiring clinicians earn white coats during annual ceremonies

Weill Cornell Medicine celebrated the incoming physician assistant students in the Class of 2028 and first-year medical students in the Class of 2030 Aug. 18 during two White Coat Ceremonies.

Robertsons champion real-world learning through Shuler clinical immersion program

Inspired by the hands-on experiences that shaped their own careers, Beckie Robertson ’82 and Neil Robertson ’82 have endowed the Michael Shuler Clinical Immersion Program in Biomedical Engineering, ensuring future Cornell students gain firsthand exposure to patient care and clinical problem-solving.

Around Cornell

Traumatic brain injury in Pakistan linked to poor long-term survival

Traumatic brain injury in Pakistan is associated with a high risk of death and disability long after the initial injury, even in mild to moderate cases.

Protein secreted by immune cells may help drive brain aging

Brain-resident immune cells that have reached an old-age state called “senescence” secrete a protein that causes dysfunction in other brain cells, according to Weill Cornell Medicine researchers, a finding that could shed light on memory loss.

Molecular structures provide roadmap for targeted Parkinson’s disease therapeutics

Researchers have uncovered how a key Parkinson’s protein shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state.